Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia

Update Il y a 4 ans
Reference: NCT01963598

Woman and Man

Extract

This is a randomized, double-blind, placebo-controlled, multicenter phase 2 study of the safety and efficacy of 3-month subcutaneous (SC) REGN1033 (SAR391786) treatment in patients with sarcopenia.


Inclusion criteria

  • Sarcopenia


Links